Engimmune Therapeutics raises CHF15.5m in seed financingCancer specialist Engimmune Therapeutics has raised CHF15.5m in a seed financing to expand its pipeline of T-cell receptor therapeutics. more ➔
Switzerland shows sustained growth of biotech sectorThe Swiss Biotech sector has again attracted record-breaking investments in 2021, according to the Swiss Biotech Report that was presented at the Swiss Biotech Day 2022 in Basel. more ➔
Commission to establish EU health data spaceDigital medicine holds great opportunities. The EU Commission is therefore presenting a draft law this week that defines rules for a European Health Data Space. more ➔
Four new autoantigens trigger multiple sclerosisSwiss and Swedish researchers have uncovered four previously unkown autoantigens that trigger multiple sclerosis in mice. more ➔
TWB partners with Processium and SyngulonIndustrial biotech project managment specialist Toulouse White Biotech (TWB) has joined forces with process developer Processium and industrial synbio start-up Syngulon. more ➔
Meat consumption must fall by at least 75 percentIf our planet is to continue feeding us in the future, rich countries must significantly reduce their meat consumption by at least 75% suggests a new study by German researchers. more ➔
Vigeneron updates gene therapy collab with Daiichi SankyoViGeneron and Daiichi Sankyo have agreed a follow-on collaboration to evaluate vgAAVs as vectors for Daiichi Sankyo’ novel treatment of prevalent eye diseases. more ➔
Single-use market to reach $20.8bn by 2026 Analysts from Markets & Markets today released the report "Single use Bioprocessing Market by Product. more ➔
Study shows advantages of cellular agricultureNovel foods derived from cell culture instead of animals reduce the environmental impact of diets, water and land use by 80%, report Finnish researchers. more ➔
EMA delays Valneva vaccine approvalThe approval of Valneva’s Corona vaccine is delaying. The European Medicines Agency’s CHMP requested additional data. more ➔
